Home / France / Solutions 30 SE
Solutions 30 SE
Short position disclosed on September 11, 2026.
1.19% of the capital sold short
2 disclosing funds
460 disclosures on record
FR0013379484 ISIN code
Evolution of the disclosed total
0%1%2%3%4%
Oct 2025Jan 2026Apr 2026Jul 2026
May 17, 2019 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| GSA Capital Partners LLP | 0.60% | new | September 11, 2026 | |
| Connor, Clark & Lunn Investment Management LTD. | 0.59% | new | August 26, 2026 |
In the United States SLUNF (OTC): 29,894 shares sold short on August 31, 2026. FINRA names no fund.
On the other side: the funds that hold Solutions 30 SE Titelia
Get the moves on Solutions 30 SE by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| January 21, 2025 | Qube Research & Technologies Limited | 0.00% | January 23, 2025 |
| January 17, 2025 | Qube Research & Technologies Limited | 0.57% | January 23, 2025 |
| January 10, 2025 | Qube Research & Technologies Limited | 0.60% | January 23, 2025 |
| January 8, 2025 | Citadel Securities (Europe) Limited | 0.62% | February 20, 2025 |
| January 8, 2025 | Qube Research & Technologies Limited | 0.58% | January 23, 2025 |
| January 6, 2025 | Citadel Securities (Europe) Limited | 0.58% | February 20, 2025 |
| January 3, 2025 | GSA Capital Partners LLP | 0.59% | May 2, 2025 |
| December 27, 2024 | GSA Capital Partners LLP | 0.68% | May 2, 2025 |
| December 16, 2024 | Qube Research & Technologies Limited | 0.68% | January 23, 2025 |
| December 9, 2024 | Citadel Securities (Europe) Limited | 0.61% | February 20, 2025 |
| December 6, 2024 | Qube Research & Technologies Limited | 0.77% | January 23, 2025 |
| December 6, 2024 | Citadel Securities (Europe) Limited | 0.59% | February 20, 2025 |
| December 5, 2024 | Citadel Securities (Europe) Limited | 0.60% | February 20, 2025 |
| November 22, 2024 | Tages Capital LLP | 1.12% | August 26, 2025 |
| November 22, 2024 | GSA Capital Partners LLP | 0.70% | May 2, 2025 |
| November 21, 2024 | Tages Capital LLP | 1.07% | August 26, 2025 |
| November 19, 2024 | Tages Capital LLP | 0.90% | August 26, 2025 |
| November 14, 2024 | Qube Research & Technologies Limited | 0.88% | January 23, 2025 |
| November 13, 2024 | Tages Capital LLP | 0.82% | August 26, 2025 |
| November 12, 2024 | Tages Capital LLP | 0.69% | August 26, 2025 |
| November 12, 2024 | Citadel Securities (Europe) Limited | 0.56% | February 20, 2025 |
| November 6, 2024 | Qube Research & Technologies Limited | 0.96% | January 23, 2025 |
| November 5, 2024 | GSA Capital Partners LLP | 0.61% | May 2, 2025 |
| November 4, 2024 | Qube Research & Technologies Limited | 1.04% | January 23, 2025 |
| October 31, 2024 | Tages Capital LLP | 0.52% | August 26, 2025 |
| October 25, 2024 | GSA Capital Partners LLP | 0.52% | May 2, 2025 |
| October 24, 2024 | Qube Research & Technologies Limited | 1.17% | January 23, 2025 |
| October 15, 2024 | Qube Research & Technologies Limited | 1.26% | January 23, 2025 |
| October 11, 2024 | Qube Research & Technologies Limited | 1.33% | January 23, 2025 |
| October 10, 2024 | Qube Research & Technologies Limited | 1.41% | January 23, 2025 |
| October 3, 2024 | Qube Research & Technologies Limited | 1.33% | January 23, 2025 |
| October 2, 2024 | Citadel Securities (Europe) Limited | 0.49% | October 4, 2024 |
| September 26, 2024 | Citadel Securities (Europe) Limited | 0.57% | October 4, 2024 |
| September 19, 2024 | Qube Research & Technologies Limited | 1.23% | January 23, 2025 |
| September 12, 2024 | Citadel Securities (Europe) Limited | 0.69% | October 4, 2024 |
| September 5, 2024 | Qube Research & Technologies Limited | 1.18% | January 23, 2025 |
| September 3, 2024 | Qube Research & Technologies Limited | 1.21% | January 23, 2025 |
| August 28, 2024 | GSA Capital Partners LLP | 0.49% | August 30, 2024 |
| August 16, 2024 | GSA Capital Partners LLP | 0.50% | August 30, 2024 |
| August 14, 2024 | Citadel Securities (Europe) Limited | 0.79% | October 4, 2024 |
| August 7, 2024 | Qube Research & Technologies Limited | 1.10% | January 23, 2025 |
| August 6, 2024 | Qube Research & Technologies Limited | 1.08% | January 23, 2025 |
| August 5, 2024 | Qube Research & Technologies Limited | 1.11% | January 23, 2025 |
| July 26, 2024 | Citadel Securities (Europe) Limited | 0.82% | October 4, 2024 |
| July 25, 2024 | Qube Research & Technologies Limited | 1.08% | January 23, 2025 |
| July 25, 2024 | Citadel Securities (Europe) Limited | 0.79% | October 4, 2024 |
| July 23, 2024 | Qube Research & Technologies Limited | 0.90% | January 23, 2025 |
| July 22, 2024 | Qube Research & Technologies Limited | 0.86% | January 23, 2025 |
| July 19, 2024 | Qube Research & Technologies Limited | 0.90% | January 23, 2025 |
| July 19, 2024 | Citadel Securities (Europe) Limited | 0.62% | October 4, 2024 |
Download 460 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Ubisoft Entertainment 12.49% of the capital sold short
- Valeo 11.40% of the capital sold short
- Renault 9.16% of the capital sold short
- Viridien 8.08% of the capital sold short
- Teleperformance 7.58% of the capital sold short
- FDJ United 6.19% of the capital sold short
- Abivax 5.10% of the capital sold short
- Elis 4.91% of the capital sold short
- Alstom 4.57% of the capital sold short
- Rémy Cointreau 4.46% of the capital sold short
- Sopra Steria Group 3.92% of the capital sold short
- Spie SA 3.75% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Solutions 30 SE, source AMF, data as at September 11, 2026, https://www.quivad.com/action/solutions-30-se?page=3